HEMLIBRA® recommended dosage

The recommended dose is 3 mg/kg by subcutaneous injection once weekly for the first 4 weeks, followed by 1.5 mg/kg once weekly.

Missed dose

If a dose of HEMLIBRA is not administered on the scheduled day, administer as soon as possible before the day of the next scheduled dose, and then resume usual weekly dosing schedule. Do not double doses to make up for a missed dose.

HEMLIBRA is for subcutaneous use only.

Dosage forms & strengths

HEMLIBRA is available as a colorless to slightly yellow solution in single-dose vials (1 per carton):

  • 60 mg, 105 mg, and/or 150 mg vials are the same concentration (150 mg/mL) and may be combined
  • 30 mg vials (30 mg/mL) should not be combined with 60 mg, 105 mg, and/or 150 mg vials

Dosing guide

Use the dosing guide to help you determine the recommended loading and maintenance dose of HEMLIBRA and the most appropriate vial(s) to prescribe according to your patient’s weight. Download the dosing guide here.

Dosing Guide

Download the HEMLIBRA Dosing Guide

HEMLIBRA Webcast

Stay up-to-date with informative webcast events

Preparation & Administration

Getting ready to administer a HEMLIBRA injection